Department of Internal Medicine

Arthur Swislocki, M.D. View profile as PDF

Philosophy of Care

Dr. Swislocki tries to involve the patient as a team member since the conditions we are treating are lifelong and require the patient's active involvement to the best of their ability. His role is to educate and encourage them, and to provide them the resources they need to be successful.

Title:

Professor in Residence, Step III

Specialty:

Endocrinology, Diabetes, and Metabolism

Other Languages:

French, Spanish

Education:

UCLA School of Medicine
Los Angeles, California
M.D. 1979

UCLA
Los Angeles, California
M.A. 1973

UCLA
Los Angeles, California
B.A. 1972

Internships:

LA County/USC Medical Center
Los Angeles, CA
1979-80

Residency:

UC Davis Medical Center (Chief Resident)
Sacramento, CA
1982-83
Internal Medicine

UC Davis Medical Center
Sacramento, CA
1980-82
Internal Medicine

Fellowships:

Stanford University Medical Center
Stanford, CA
1984-86
Endocinology (Int Med)

Stanford University Medical Center
Stanford, CA
1984-86
Clin. Pharmacology

Board Certifications:

American Board of Endocrinology, Diabetes and Metobolism, 1989
American Board of Internal Medicine, 1982

Professional Memberships:

American College of Physicians
American Diabetes Association
American Federation for Medical Research
The Endocrine Society

Honors and Awards:

Member, VISN 21 Endocrinology Advisory Board, 2012
Recognition as an "Outstanding Reviewer," by the Editor, Annals of Internal Medicine, 2009
Recognition as an "Outstanding Reviewer," by the Editor, Annals of Internal Medicine, 2008
Attending of the year, Medical Service, Martinez DVAMC, 1990

Select Recent Publications:

Kelley, D.S., Y. Adkins, L. R Woodhouse, A. Swislocki, B. E. Mackey, and D. Siegel (2012). DHA Supplementation Improved Lipocentric But Not Glucocentric Markers of Insulin Sensitivity in Hypertriglyceridemic Men. Metab Syndr Relat Disord; 10: 32-38.

Swislocki, A.L.M., D. Siegel, and I. Jialal (2012). Pharmacotherapy for the Metabolic Syndrome. Invited Review, Curr Vasc Pharmacol; 10: 187-205.

Swislocki, A.L.M., J.L. Meier, S.M. Najera, and R. H. Noth (2011). Long-term maintenance of glucose control in veterans with type 2 diabetes mellitus using oral agents. Metab Syndr Relat Disord; 9: 469-73.

Garcia, E., J.R. Lopez, J.L. Meier, A.L.M. Swislocki, and D. Siegel (2011). Resistant Hypertension and Undiagnosed Primary Hyperaldosteronism Detected by Use of a Computerized Database. J Clin Hypertens, 13: 487-491.

Siegel, D, and A.L.M. Swislocki (2011). The ACCORD Study: The Devil is in the Details. Invited commentary. Metab Syndr Relat Disord; 9: 81-4. 2010 Dec 18. [Epub ahead of print]

Libby, A., J. Meier, J. Lopez, A.L.M. Swislocki, and D. Siegel (2010). The effect of body mass index on fasting blood glucose and development of diabetes mellitus after initiation of extended-release niacin. Metab Syndr Relat Disord; 8:79-84.

A. Swislocki, J.A. Green, G. Heinrich, C.A. Barnett, I. Meadows, E.B. Harmon, and R. Noth (2010). Prevalence of osteoporosis in a male nursing home population. Am J Man Care; 16: 427-33.

Siegel, D, and A.L.M. Swislocki (2010). Hypertensive Treatment in Patients with the Metabolic Syndrome. Invited review, Metab Syndr Relat Disord; 8: 95-103.

Keane, J, J.L. Meier, R.H. Noth, and A.L.M. Swislocki (2009). Computer-based screening of veterans for metabolic syndrome. Metab Syndr Relat Disord, 7: 557-61.

Swislocki, A, M. Orth, M. Bales, J. Weisshaupt, C. West, J. Edrington, B. Cooper, L. Saputo, M. Islas, and C. Miaskowski (2010). A randomized controlled trial of the effectiveness of photon stimulation on pain, sensation, and quality of life in patients with diabetic peripheral neuropathy. J Pain Symptom Manage; 39: 88-99. Epub 2009 Nov 5.